Virax Biolabs Group Ltd (NASDAQ:VRAX) concluded the trading at $2.34 on Wednesday, January 08 with a fall of -15.52% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $2.77 and 5Y monthly beta was reading 1.925 with its price kept floating in the range of $2.14 and $2.73 on the day. Considering stock’s 52-week price range provides that VRAX hit a high price of $9.00 and saw its price falling to a low level of $0.60 during that period. Over a period of past 1-month, stock came adding 30.73% in its value.
In contrast, when we review VRAX stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of Hold. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the VRAX stock which is currently positioned at 0. It further provides that stock’s current price level is 15.33% away from its 20-day simple moving average and is 16.78% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 53.92 while volatility remained at 23.48% over the past week which changes to 18.67% when measuring it over the past month. Beta is valued at 1.64, while measure of average true range or ATR is currently at 0.38.
Having a second look at Virax Biolabs Group Ltd (NASDAQ:VRAX) provides that stock’s average daily trading volume for 3 months was 1.84 million, while it jumped to 733400 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 4.34 million.
The percentage of outstanding shares held by the insiders is 6.63% while it is 10.28% for the institutional holders. The figures also indicate that as of 2024-10-31, number of stock’s short shares was 0.45 million which implies a short ratio of 0.11. This shows up a 1101.00 of Short Interest in company’s outstanding shares on the day. In October the standing of shares short improved as it was 0.26 million in the previous month. Addition of 4.00% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
